2016 ASCO临床实践指南:女性早期浸润性乳腺癌患者使用生物标志物指导辅助性全身治疗
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women with Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
This guideline provides evidence-based recommendations to practicing oncologists and other stakeholders on the appropriate use of breast tumor biomarker assay results to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer with known hormone receptor (estrogen and progesterone receptors [ER/PgRs]) and human epidermal growth factor receptor 2 [HER2]) status. In an era of great interest in personalized, precision medicine, the role of tumor biomarker assays in guiding clinical care has taken on even greater importance than in the past.
学科代码:肿瘤学 关键词:女性 早期浸润性乳腺癌 生物标志物 ,指南 爱思唯尔医学网, Elseviermed
顶一下(0)
- 您可能感兴趣的指南
-